TISSUE-SPECIFIC THERAPEUTICS (TSTX)
Dead / Abandoned — Abandoned — failure to respond (as of 04 May 2024)
What this means for you
This application is over — abandoned 15 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90816280
- Mark type
- Stylized text
- Filed
- 07 Jul 2021
- Abandoned
- 15 Apr 2024
- Attorney of record
- Sheila R. Gibson
Goods and services
- Class 005 — Pharmaceuticals: Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
Owner
- Immix Biopharma, Inc., Los Angeles, CA, US
Prosecution history
- 04 May 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 04 May 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 16 Jan 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 16 Jan 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Oct 2023 — NON-FINAL ACTION E-MAILED
- 14 Oct 2023 — NON-FINAL ACTION WRITTEN
- 10 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Nov 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Nov 2022 — ASSIGNED TO LIE
- 28 Sept 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED